followup CT scan. Procedurerelated complications were also documented. Patient data were compiled from the admission files and intensive care unit (ICU) charts.
Results
The injury pattern, injury severity, comorbidities and ICU stay data are shown in Table 1 . The patients showed a typical injury pro file that affected the timing and planning of the stent graft pro cedure. Of the 55 patients, 32 were treated on day 1 of ad mission, and the remainder between days 2 and 5. In 9 cases, another op erative procedure was performed during the same anaesthesia (7 orthopaedic, 2 neurosurgical). Neurological injuries were con firmed on CT scans, and seven of these required neurosurgical inter ventions. Twentyone patients with longbone fractures required orthopaedic surgery within 24 hours of sustaining their injuries. The patients with lung injuries had Xray evidence of fractured ribs or parenchymal contusion. Of the 55 patients, 24 required ventilation and 15 required inotropes prior to stent graft placement. In all patients, the stent graft was successfully inserted, the aortic injury appeared to be adequately treated and no endoleaks were detected.
Thirteen patients died after insertion of the stent grafts, at an average of 14 days. There was a trend that these patients were older, had a higher injury severity score (ISS) and a higher prevalence of comorbidities. None of the patients who died had preoperative CT scans and we were unable to evaluate whether a graft complication contributed to the death. However, events leading to death included pneumonia, acute respiratory distress syndrome, multiorgan dysfunction, cerebral oedema, myocardial contusion and renal failure. Table 2 also shows other complications and technical uncertainties that may have affected outcomes. Of these, 19 patients had poor apposition of the stent graft to the inner curve of the aortic arch. This is likely to be due to significant stent graft oversizing in an acutely shaped aortic arch. Stent graft collapse is a potential complication of this and was seen in a 20yearold patient who presented at 6 months followup with incomplete collapse of the proximal portion of a GORE TAG stent graft. His presenting problem at this time was severe hypertension, and he was treated by elective open repair of the aorta and removal of the stent graft; he recovered uneventfully.
In one patient, the left common carotid artery was inadvertently covered during stent graft deployment. This was treated during the same procedure by retrograde insertion of a left carotid 'chimney' peripheral stent graft to reestablish flow into the carotid artery.
One patient developed an ischaemic lower limb 24 hours after stent graft insertion and required a femoral embolectomy. In 24 patients, the left subclavian artery (LSA) was intentionally covered with the stent graft in order to secure the proximal part of the graft in a horizontal part of the arch. A potential complication of this was posterior cerebral or left arm ischaemia. None of this was apparent, but we cannot rule this type of complication out as 13 patients had associated head injuries. In this small series, none of these complications appeared to affect mortality. Of the 42 survivors, 19 followup CT scans were available at 6 months, 6 at 1 year and 2 at 2 years. Although all patients were asked to return for followup and contact details were documented, we were still unable to trace many from the details supplied.
The stent graft characteristics in Table 3 indicate oversizing by up to 30%. Fifteen patients were oversized in excess of 20% as smallersize grafts were not available. The longterm outcome of this is unknown and, as followup was poor, this remains a particular concern.
Discussion
TEVAR is rapidly being accepted as the standard of care to treat BTAI. The evolution of stent grafts and a better understanding of the natural history of the aortic injury are likely to improve outcomes in the future.
Although we were able to treat severely injured patients by apparently successful TEVAR, >25% still succumbed to their injuries. The numbers in this series are small and it is not possible at present to identify a subgroup of critically injured patients who would have died despite TEVAR. Many of these patients would not have been offered intervention in the past owing to the high risk associated with open surgery. There is likely to be a trend towards aggressive TEVAR management in patients with BTAI.
We have demonstrated that complications such as leg ischaemia and carotid ostial compromise, while uncommon, are still possible and may affect outcomes if not dealt with appropriately.
Of more concern is the lack of longterm data in young patients treated with TEVAR. Very few areas of vascular medicine demand stringent followup in excess of 30 years. The poor graft apposition to the inner curve, the excessive oversizing and the single case of graft collapse in this study support this view. Some of these concerns may be addressed by the current availability of smaller stent grafts (20 mm) and the more extensive use of infrarenal aortic extender cuffs. In the future, fenestrated grafts may solve the problem of LSA coverage.
Followup remains a major concern, and novel strategies such as medical alert bracelets may need to be assessed. We recommend that, where possible, multiple family members be informed of the need for followup. The notion that TEVAR is considered a damage control strategy and that a subset of patients undergo elective open surgery if stable, requires further investigation.
In view of these findings, it is imperative that interventionists pay attention to detail and adopt the most appropriate stent graft strategy for individual patients. Under stressful emergency situations one often forgets the potential longterm complications and uses what is available rather than what is appropriate. Inevitable complications are best treated by highvolume vascular centres.
Conclusion
The evolution of TEVAR as the standard of care in patients with BTAI is likely to be associated with longterm complications that we have not yet realised. The implementation of institutional protocols regarding stent graft measurements and followup may be helpful. In the future, lowerprofile, archdedicated fenestrated stent grafts may alleviate current problems.
